4//SEC Filing
Wilson Marc 4
Accession 0001209191-24-000812
CIK 0001658247other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:43 PM ET
Size
9.4 KB
Accession
0001209191-24-000812
Insider Transaction Report
Form 4
Wilson Marc
CFO
Transactions
- Exercise/Conversion
Common Stock
2024-01-02$9.28/sh+10,000$92,800→ 106,055 total - Exercise/Conversion
Non-qualified stock option (Right to Buy)
2024-01-02−10,000→ 51,185 totalExercise: $9.28Exp: 2028-05-24→ Common Stock (10,000 underlying) - Sale
Common Stock
2024-01-02$35.47/sh−10,000$354,700→ 96,055 total
Footnotes (4)
- [F1]Includes 454 shares acquired under the Issuer's Employee Stock Purchase.
- [F2]The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan.
- [F3]The common stock was sold by the Reporting Person in open market transactions on the transaction date with a volume weighted average sales price of $35.47 per share. The range of sales prices on the transaction date was $34.41 to $36.07 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.
- [F4]1/48th of the shares subject to the option vested on June 25, 2018, and 1/48th of the shares subject to the option vested monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001702265
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:43 PM ET
- Size
- 9.4 KB